Tesla's stock surge may not align with its weakening fundamentals, cash concerns, and high valuation. Read here for an ...

Tesla's investment case now hinges more on the upcoming robotaxi launch and FSD progress than on immediate vehicle sales ...

Despite Trade War, U.S. Drug Companies Turn to China for Key Cancer Treatments U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could ...

Mark Tucker previously served as AIA's group chief executive and president from 2010 to 2017. Amazon plans to invest over $5 billion in a cluster of data centers in Taiwan. The investment will support ...

Elon Musk's renewed 24/7 commitment to Tesla surged investor confidence Tuesday. This focus, alongside robotaxi plans and ...

Euro (EUR) could potentially retest 1.1495 against US Dollar (USD) or even break above this level; slowing momentum suggests ...

With an unchanged price target of $410, Morgan Stanley analyst Adam Jonas maintained a Buy rating on Tesla Inc. (NASDAQ:TSLA) ...

Tesla (TSLA) investors haven't had much to cheer since the beginning of the year, as shares of the Elon Musk-led electric ...

Ross Gerber still doesn't think the pain is over for Tesla. Gerber's firm dumped more of the stock last quarter ... Gerber-Kawasaki Wealth and Investment Management, shows that the investor ...

This move underscores ARK’s confidence in the genomic company, which has been a recurring interest for the investment ... outlook in these sectors, while the divestments from companies like ...

After soaring in 2023 and 2024, shares of Tesla (NASDAQ:TSLA) was battered throughout Q1 2025. But since the start of Q2, the ...

Wedbush expects significant value to be unlocked through Tesla’s full self-driving (FSD) technology and the rollout of its ...